Relmada Therapeutics (RLMD)
(Delayed Data from NSDQ)
$3.27 USD
+0.03 (0.93%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $3.24 -0.03 (-0.92%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.56 | 0.00% |
Earnings Summary
For their last quarter, Relmada Therapeutics (RLMD) reported earnings of -$0.59 per share, beating the Zacks Consensus Estimate of $-0.83 per share. This reflects a positive earnings surprise of 28.92%. Look out for RLMD's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.56 per share, reflecting a year-over-year increase of 23.29%.
Earnings History
Price & Consensus
Zacks News for RLMD
Relmada (RLMD) Up on Positive Data for Anti-Depressant Candidate
RLMD: What are Zacks experts saying now?
Zacks Private Portfolio Services